Surprisingly, in contrast to treatment studies on acute myeloid leukemia and small‐cell lung cancer (Mohammad et al., 2015; Stazi et al., 2016), conventional MAO‐based LSD1 inhibitors neither affected the histone methylation status, nor influenced NSCLC cell growth. The gene discussed is KDM1A; the disease is acute myeloid leukemia.